Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis

Hemodialysis International

Volumn 17, Issue 3, 2013, Pages 397-405

  Yildiz, Gürsel ^a   Duman, Alptekin ^c   Aydin, Hüseyin ^c   Yilmaz, Abdulkerim ^c   Hür, Ender ^b   Maǧden, Kemal ^b   Çetin, Gülay ^d   Candan, Ferhan ^c  

^a Ataturk State Hospital   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c CUMHURIYET UNIVERSITY   (Turkey)

^d Sivas Devlet Hastanesi   (Turkey)

Author keywords

Atherogenic index of plasma; Carotid artery intima media thickness; Hemodialysis patients; Subclinic athersclerosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENIC INDEX OF PLASMA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84879604107     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12041     Document Type: Article

References (52)

1. Locatelli F, Pozzoni P, Tentori F, Del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant. 2003; 18:2-9.
2. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000; 356:147-152.
3. Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E. Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol. 2003; 60:13-21.
4. Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: Epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab. 1999; 25:199-211.
5. Vakkilainen J, Steiner G, Ansquer JC, etal. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: The Diabetes Atherosclerosis Intervention Study (DAIS). Circulation. 2003; 107:1733-1737.
6. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109:2-7.
7. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDLC) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL)). Clin Biochem. 2001; 34:583-588.
8. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation. 1986; 74:1399-1406.
9. O'Leary DH, Polak JF. Intima-Media Thickness: A tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002; 90:18-21.
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296-1305.
11. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006; 296:1377-1384.
12. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002; 13:745-753.
13. Nakayama M, Metoki H, Terawaki H, etal. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese popuiation-the Ohasama study. Nephrol Dial Transplant. 2007; 22:1910-1915.
14. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G. Echo color Doppler imaging of carotid vessels in hemodialysis patients: Evidence of high levels of atherosclerotic lesions. Am J Kidney Dis. 1996; 28:713-720.
15. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002; 16:341-351.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340:14-22.
17. Madhu SV, Kant S. Preclinical evaluation of atherosclerosis. Int J Diab Dev Ctries. 2006; 26:105-111.
18. Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine Study. Circulation. 1999; 100:838-842.
19. Nishizawa Y, Shoji T, Maekawa K, etal. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003; 41:76-79.
20. Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs. 2000; 24:691-695.
21. Chambless LE, Heiss G, Folsom AR, etal. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997; 146:483-494.
22. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation. 1997; 96:1432-1437.
23. Baldassarre D. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 2000; 31:2426-2430.
24. del Sol AI. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke. 2001; 32:1532-1538.
25. Mukherjee D, Yadav JS. Carotid artery intimal-medial thickness: Indicator of atherosclerotic burden and response to risk factor modification. Am Heart J. 2002; 144:753-759.
26. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int. 2003; 64:1472-1479.
27. Ekart R, Hojs R, Hojs-Fabjan T, Balon BP. Predictive value of carotid intima media thickness in hemodialysis patients. Artif Organs. 2005; 29:615-619.
28. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001; 12:2458-2464.
29. Caliskan Y, Ozkok A, Akagun T, etal. Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients. Kidney Blood Press Res. 2012; 35:340-348.
30. Wanner C. Importance of hyperlipidaemia and therapy in renal patients. Nephrol Dial Transplant. 2000; 15:92-96.
31. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis. 1998; 32:142-156.
32. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease. Overall burden and rates of treatment and control. Arch Intern Med. 2006; 166:1884-1891.
33. Williams PT, Superko HR, Haskell WL, etal. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol. 2003; 23:314-321.
34. Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression on coronary artery disease in the Provastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol. 2002; 90:89-94.
35. Mohan V, Deepa R, Velmurugan K, Gokulakrishnan K. Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians-The Chennai Urban Epidemiology Study (CURES 8). J Assoc Physcians India. 2005; 53:95-100.
36. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003; 31:1066-1069.
37. Dobiásová M. AIP-Atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice. Vnitr Lek. 2006; 52:64-71.
38. Dobiasova M, Frohlich J. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003; 49:1873-1880.
39. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in nondiabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb. 2003; 10:186-191.
40. Ambrosch A, Domroese U, Westphal S, etal. Compositional and functional changes of low-density lipoprotein during hemodiaiysis in patients with ESRD. Kidney Int. 1998; 54:608-617.
41. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999; 55:389-399.
42. Ando M, Lundkvist L, Bergstrom J, Lindholm B. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int. 1996; 49:773-780.
43. Bayes B, Pastor MC, Bonal J, etal. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant. 2003; 18:106-112.
44. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005; 112:651-657.
45. Tsimikas S, Brilakis ES, Lennon RJ, etal. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res. 2007; 48:425-433.
46. Nishi K, Itabe H, Uno M, etal. Oxidized LDL in carotid plaques and plasma associates with plaque nstability. Rterioscler Thromb Vase Biol. 2002; 22:1649-1654.
47. Ehara S, Ueda M, Naruko T, etal. Elevated levels of oxidized low dansity lipoprotein show a positive relationship with the severity of acute coronary sendromes. Circulation. 2001; 103:1955-1960.
48. Koch M, Kutkuhn B, Trenkwalder E, etal. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 1997; 8:1889-1898.
49. Hodis HN, Mack WJ, LaBree L, etal. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998; 128:262-269.
50. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima- media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol. 2002; 90:953-958.
51. Nassiri AA, Hakemi MS, Asadzadeh R, etal. Differences in cardiovascular disease risk factors associated with maximum and mean carotid intima-media thickness among hemodialysis patients. Iran J Kidney Dis. 2012; 6:203-208.
52. Falaknazi K, Tajbakhsh R, Sheikholeslami FH, etal. Evaluation of association between intima-media thickness of the carotid artery and risk factors for cardiovascular disease in patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl. 2012; 23:31-36.